Ensysce Biosciences Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Ensysce Biosciences Stock Summary

Ensysce Biosciences competes with Palisade Bio, Quoin Pharmaceuticals, Revelation Biosciences, Virax Biolabs, and Unicycive Therapeutics. Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It is also developing PF329, an extended-release prodrug of hydromorphone that is similar to PF614 PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for ADHD medication abuse and PF26810, an extended-release prodrug of methadone for opioid use disorder. Ensysce Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 6 people.

Ensysce Biosciences Key Financial Ratios

Ensysce Biosciences Key Balance Sheet Accounts

Ensysce Biosciences Key Income Statement Accounts

Ensysce Biosciences Key Cash Accounts

Ensysce Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ensysce Biosciences's current stock value. Our valuation model uses many indicators to compare Ensysce Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ensysce Biosciences competition to find correlations between indicators driving Ensysce Biosciences's intrinsic value. More Info.Ensysce Biosciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Ensysce Biosciences' Return On Equity is projected to increase based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ensysce Biosciences' earnings, one of the primary drivers of an investment's value.

Ensysce Biosciences Systematic Risk

Today, most investors in Ensysce Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ensysce Biosciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Ensysce Biosciences growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Ensysce Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ensysce Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ensysce Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Ensysce Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ensysce Biosciences's daily price indicators and compare them against related drivers.

When running Ensysce Biosciences' price analysis, check to measure Ensysce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ensysce Biosciences is operating at the current time. Most of Ensysce Biosciences' value examination focuses on studying past and present price action to predict the probability of Ensysce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ensysce Biosciences' price. Additionally, you may evaluate how the addition of Ensysce Biosciences to your portfolios can decrease your overall portfolio volatility.